Who owns the DR.BABOON trademark?

The DR.BABOON trademark is owned by Niusaisi Guangzhou Biotechnology Co., Ltd..

What class is the DR.BABOON trademark registered in?

The DR.BABOON trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DR.BABOON?

The USPTO serial number for DR.BABOON is 99810117.

What is the registration number for DR.BABOON?

DR.BABOON is registered under USPTO registration number 0.

Sealvo

Home Search: DR.BABOONDR.BABOON #99810117

Back

Updated Oct 7, 2026·42 searches this week

View on USPTO TSDR Find similar marks

DRB

USPTO Trademark Record

PENDING

DR.BABOON

SN 99810117·Reg 0·Filed May 07, 2026

Owner Niusaisi Guangzhou Biotechnology Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DR.BABOON (Serial No. 99810117), Registration No. 0, is a pending US trademark filed on May 07, 2026 by Niusaisi Guangzhou Biotechnology Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Opposition window open — 29 days left to challengeURGENT

Mark Intelligence

DR.BABOON (Reg. #0) is a pending US trademark that was filed in 2026 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 07, 2026

SERIAL

99810117

REG#

Filing Information

StatusPENDING

Filing DateMay 07, 2026

Serial Number99810117

Registration No.0

Status DateOct 06, 2026

Published for OppositionOct 06, 2026